Organization & Developments: Enable Injections

Parents

2026: Inside the first-of-its-kind Enable Injections enFuse drug delivery wearable
Based on its unique Enable enFuse technology, the company offers an innovative drug delivery technology designed to subcutaneously deliver large volumes of up to 50mL for a wide range of therapies and diseases.
This allows for a safe, convenient, and cost-effective alternative to IV administration.
While multiple companies support the delivery of drug volumes of 3 ml and under, few businesses have devices that cater to larger volumes that cannot be quickly administered under the skin.